Benefits of aldosterone receptor antagonism in chronic kidney disease: the BARACK-D RCT.Published in:Health Technology Assessment, 2025, v. 29, n. 5, p. 1, doi. 10.3310/PYFT6977By:Hobbs, F D Richard;McManus, Richard;Taylor, Clare;Jones, Nicholas;Rahman, Joy;Wolstenholme, Jane;Jones, Louise;Hirst, Jennifer;Mort, Sam;Yu, Ly-MeePublication type:Article